Ardelyx Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for patients with cardiorenal and gastrointestinal diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!